Banque Pictet & Cie’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Banque Pictet & Cie's RGEN Position: Q1 2026 in Review
Banque Pictet & Cie reduced its Repligen (RGEN) stake by 77% in Q1 2026, selling an estimated $1.93M and leaving 4,087 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #309.
Banque Pictet & Cie first reported a position in RGEN in Q2 2022 and has held it in 16 quarters since. The position peaked at $7.5M in Q4 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Banque Pictet & Cie held 4,087 shares of Repligen worth $482K as of Q1 2026.
- Banque Pictet & Cie sold 13,823 Repligen shares in Q1 2026, an estimated $1.93M.
- Repligen made up ﹤0.01% of Banque Pictet & Cie's portfolio in Q1 2026, its #309 holding.
- Banque Pictet & Cie first reported a position in Repligen in Q2 2022 and has held it in 16 quarters since.
- Banque Pictet & Cie's Repligen position peaked at $7.5M in Q4 2023.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Banque Pictet & Cie's 13F filing for Q1 2026, filed 14 Apr 2026.